Frontlight ResearchEarly access
Ventricular tachycardia trials in Norway
1 of 1 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleSafety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
- Where
- Oslo
- Age
- 18 years to 75 years
- People
- 10
- Run by
- Agiana Pharmaceuticals
See details and how to joinNCT07263139 · EU 2025-521611-39-00